Aprea Therapeutics, Inc. (APRE)
USD 1.57
(-7.65%)
USD 1.57
(-7.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.17 Million | -25.01 Million | -37.68 Million | -41.8 Million | -26.7 Million | -15.25 Million |
| Net Income | -14.28 Million | -112.66 Million | -37.12 Million | -53.47 Million | -28.05 Million | -15.52 Million |
| Depreciation & Amortization | 7052.00 | 186.44 Thousand | 271.67 Thousand | 229.61 Thousand | 170.25 Thousand | 8316.00 |
| Deferred income taxes | -827.46 Thousand | - | - | - | - | - |
| Stock-based compensation | 444.45 Thousand | 16.98 Million | 7.81 Million | 4.98 Million | 1.34 Million | 329.18 Thousand |
| Change in working capital | 1.61 Million | -1.75 Million | -8.32 Million | 5.57 Million | 1.16 Million | 901.85 Thousand |
| Other non-cash items | 866.38 Thousand | 72.24 Million | -317.4 Thousand | 890.25 Thousand | -1.32 Million | -961.31 Thousand |
| Investing Cash Flow | -93.09 Thousand | - | - | -25.7 Thousand | -30.9 Thousand | -3702.00 |
| Investments in PPE | -93.09 Thousand | - | - | -25.7 Thousand | -30.9 Thousand | -3702.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5.13 Million | 682.97 Thousand | 1.74 Million | 150.94 Thousand | 92.57 Million | 56.36 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.78 Million | 682.97 Thousand | 1.53 Million | 150.94 Thousand | 86.9 Million | 56.36 Million |
| Other Financing Activities | -648.92 Thousand | - | 208.36 Thousand | 150.94 Thousand | 5.66 Million | 56.36 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 827.46 Thousand | -858.51 Thousand | -2.73 Million | 2.32 Million | 437.51 Thousand | 214.38 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 791.24 Thousand | -900.06 Thousand | -5.59 Million | 3.24 Million | 725.74 Thousand | 687.47 Thousand |
| Cash at beginning of period | 28.78 Million | 53.07 Million | 89.01 Million | 130.08 Million | 65.67 Million | 24.4 Million |
| Cash at end of period | 21.6 Million | 28.78 Million | 53.07 Million | 89.01 Million | 130.08 Million | 65.67 Million |
| Capital Expenditure | -93.09 Thousand | - | - | -25.7 Thousand | -30.9 Thousand | -3702.00 |
| Effect of forex changes on cash | -8399.00 | 38.75 Thousand | -2467.00 | 606.24 Thousand | -1.42 Million | 161.63 Thousand |
| Net cash flow / Change in cash | -7.17 Million | -24.28 Million | -35.94 Million | -41.07 Million | 64.41 Million | 41.27 Million |
| Free Cash Flow | -12.27 Million | -25.01 Million | -37.68 Million | -41.82 Million | -26.73 Million | -15.25 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.47 Million | -2.81 Million | -3.44 Million | -14.28 Million | -3.2 Million | -3.25 Million |
| Depreciation & Amortization | 5304.00 | 6157.00 | 4986.00 | 7052.00 | 1432.00 | 224.00 |
| Deferred income taxes | - | - | 709.19 Thousand | -827.46 Thousand | - | - |
| Stock-based compensation | 128.48 Thousand | 85.83 Thousand | 82.86 Thousand | 444.45 Thousand | 76.03 Thousand | 269.32 Thousand |
| Change in working capital | -290.92 Thousand | -1.16 Million | -425.62 Thousand | 1.61 Million | 882.2 Thousand | -170.99 Thousand |
| Other non-cash items | 570.94 Thousand | 392.22 Thousand | -791.39 Thousand | 866.38 Thousand | 2880.00 | -56.36 Thousand |
| Investing Cash Flow | -7290.46 | -7978.00 | -8559.42 | -93.09 Thousand | -84.07 Thousand | 24.84 Thousand |
| Investments in PPE | -7290.46 | -7978.00 | -8559.42 | -93.09 Thousand | -84.07 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -24.84 Thousand | - | - | - |
| Financing Cash Flow | -219.91 Thousand | 14.7 Million | 86.37 Thousand | 5.13 Million | -86.59 Thousand | -24.84 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -219.91 Thousand | 14.7 Million | 86.37 Thousand | 5.78 Million | -86.59 Thousand | -24.84 Thousand |
| Other Financing Activities | -21.06 Thousand | -1.28 Million | - | -648.92 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -343.69 Thousand | -350.25 Thousand | 802.03 Thousand | 827.46 Thousand | -267.73 Thousand | 306.33 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 52.76 Thousand | -811.35 Thousand | -1.22 Million | 791.24 Thousand | 1.14 Million | -477.32 Thousand |
| Cash at beginning of period | 32.36 Million | 21.6 Million | 25.35 Million | 28.78 Million | 27.72 Million | 30.99 Million |
| Cash at end of period | 28.69 Million | 32.36 Million | 21.6 Million | 21.6 Million | 25.39 Million | 27.72 Million |
| Capital Expenditure | -7290.46 | -7978.00 | -8559.42 | -93.09 Thousand | -84.07 Thousand | - |
| Effect of forex changes on cash | -4824.00 | -2414.00 | 383.00 | -8399.00 | -3441.00 | -53.49 Thousand |
| Net cash flow / Change in cash | -3.67 Million | 10.76 Million | -3.74 Million | -7.17 Million | -2.33 Million | -3.27 Million |
| Free Cash Flow | -3.54 Million | -3.94 Million | -3.87 Million | -12.27 Million | -2.32 Million | -3.21 Million |
TRCNF
PRABHHANS
KESKBH
YU
LALPATHLAB
ZLIOY